Kindeva Drug DeliveryKindeva Drug Delivery is a CDMO offering its partners integrated, end-to-end capabilities spanning formulation, product development, scale-up manufacturing, and commercial manufacturing. Its full-service innovation offering covers inhalation (pMDIs, DPIs, connectivity, nasal delivery); transdermal delivery (drug-in-adhesive systems, membrane systems, reservoir systems, gel patches); and intradermal delivery (microneedles based on solid and hollow microstructures). Kindeva Drug Delivery has locations in the US and the UK and employs 900 people.
